Biochemical changes accompanying apoptotic cell death in retinoblastoma cancer cells treated with lipogenic enzyme inhibitors

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1831, Issue 9, 2013, Pages 1458-1466

  Vandhana, Suryanarayanan ^a,b   Coral, Karunakaran ^a   Jayanthi, Udayakumar ^a   Deepa, Perinkulam Ravi ^b   Krishnakumar, Subramanian ^a  

^a VISION RESEARCH FOUNDATION   (India)

^b BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Apoptosis; Fatty acid synthase; Malonyl CoA; Oxidative stress; Phospholipid; Retinoblastoma

Indexed keywords

CERULENIN; CHOLESTEROL; MALONYL COENZYME A; PALMITIC ACID; PHOSPHATIDYLCHOLINE; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL; TRICLOSAN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIPID PEROXIDATION; PRIORITY JOURNAL; RETINOBLASTOMA; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84884822898     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2013.06.005     Document Type: Article

References (43)

1. O. Warburg, On the origin of cancer cells, Science 123 (1956) 309-314.
2. F. Zhang, G. Du, Dysregulated lipid metabolism in cancer, World J. Biol. Chem. 3 (2012) 167-174.
3. F.D. Camassei, R. Cozza, A. Acquaviva, A. Jenkner, L. Ravà, R. Gareri, et al., Expression of the lipogenic enzyme fatty acid synthase (FAS) in retinoblastoma and its correlation with tumor aggressiveness, Invest. Ophthalmol. Vis. Sci. 44 (2003) 2399-2403. (Pubitemid 36618394)
4. C. Wang, C. Xu, M. Sun, D. Luo, D.F. Liao, D. Cao, Acetyl-CoA carboxylase-alpha inhibitor TOFA induces human cancer cell apoptosis, Biochem. Biophys. Res. Commun. 385 (2009) 302-306.
5. T. Migita, T. Narita, K. Nomura, E. Miyagi, F. Inazuka, M. Matsuura, ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer, Cancer Res. 68 (2008) 8547-8554.
6. J.N. Thupari, M.L. Pinn, F.P. Kuhajda, Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity, Biochem. Biophys. Res. Commun. 285 (2001) 217-223. (Pubitemid 32918056)
7. Y. Gan, J. Wang, J. Coselli, X.L. Wang, Synergistic induction of apoptosis by HMG-CoA reductase inhibitor and histone deacetylases inhibitor in HeLa cells, Biochem. Biophys. Res. Commun. 365 (2008) 386-392. (Pubitemid 350148074)
8. R. Kolesnick, The therapeutic potential of modulating the ceramide/sphingomyelin pathway, J. Clin. Invest. 110 (2002) 3-8. (Pubitemid 34743457)
9. S. Vandhana, P.R. Deepa, U. Jayanthi, J. Biswas, S. Krishnakumar, Clinico-pathological correlations of fatty acid synthase expression in retinoblastoma: an Indian cohort study, Exp. Mol. Pathol. 90 (2011) 29-37.
10. S. Bakhshi, R. Bakhshi, Genetics and management of retinoblastoma, J. Indian Assoc. Pediatr. Surg. 12 (2007) 109-115.
11. J. Zhang, C.A. Benavente, J. McEvoy, J. Flores-Otero, L. Ding, et al., A novel retinoblastoma therapy from genomic and epigenetic analyses, Nature 481 (2012) 329-334.
12. D.B. Burr, S.A. Molina, D. Banerjee, D.M. Low, D.J. Takemoto, Treatment with connexin 46 siRNA suppresses the growth of human Y79 retinoblastoma cell xenografts in vivo, Exp. Eye Res. 92 (2011) 251-259.
13. P.R. Deepa, S. Vandhana, U. Jayanthi, S. Krishnakumar, Therapeutic and toxicological evaluation of anti-lipogenic agents in cancer cells compared with non-neoplastic cells, Basic Clin. Pharmacol. Toxicol. 110 (2012) 494-503.
14. T.S. Ho, Y.P. Ho, W.Y. Wong, L. Chi-Ming Chiu, Y.S. Wong, V. Eng-Choon Ooi, Fatty acid synthase inhibitors cerulenin and C75 retard growth and induce caspase-dependent apoptosis in human melanoma A-375 cells, Biomed. Pharmacother. 61 (2007) 578-587. (Pubitemid 47562696)
15. E.S. Pizer, F.J. Chrest, J.A. DiGiuseppe, W.F. Han, Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines, Cancer Res. 58 (1998) 4611-4615. (Pubitemid 28480625)
16. B. Liu, Y. Wang, K.L. Fillgrove, V.E. Anderson, Triclosan inhibits enoyl-reductase of type I fatty acid synthase in vitro and is cytotoxic to MCF-7 and SKBr-3 breast cancer cells, Cancer Chemother. Pharmacol. 49 (2002) 187-193. (Pubitemid 34185591)
17. T. Migita, S. Ruiz, A. Fornari, M. Fiorentino, C. Priolo, G. Zadra, et al., Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer, J. Natl. Cancer Inst. 101 (2009) 519-532.
18. P.R. Deepa, S. Vandhana, S. Muthukumaran, V. Umashankar, U. Jayanthi, S. Krishnakumar, Chemical inhibition of fatty acid synthase: molecular docking analysis and biochemical validation in ocular cancer cells, J. Ocul. Biol. Dis. Inform. 3 (2010) 117-128.
19. B.E. Corkey, Analysis of acyl-coenzyme A esters in biological samples, Methods Enzymol. 166 (1988) 55-70. (Pubitemid 19050732)
20. E.S. Pizer, J. Thupari, W.F. Han, M.L. Pinn, F.J. Chrest, G.L. Frehywot, C.A. Townsend, F.P. Kuhajda, Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts, Cancer Res. 60 (2000) 213-218. (Pubitemid 30070736)
21. F. Tercé, H. Brun, D.E. Vance, Requirement of phosphatidylcholine for normal progression through the cell cycle in C3H/10T1/2 fibroblasts, J. Lipid Res. 35 (1994) 2130-2142.
22. A.A. Spector, M.A. Yorek, Membrane lipid composition and cellular function, J. Lipid Res. 26 (1985) 1015-1035. (Pubitemid 16258287)
23. F.P. Kuhajda, E.S. Pizer, J.N. Li, N.S. Mani, G.L. Frehywot, C.A. Townsend, Synthesis and antitumor activity of an inhibitor of fatty acid synthase, Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 3450-3454. (Pubitemid 30183323)
24. S. Bandyopadhyay, R. Zhan, Y. Wang, S.K. Pai, S. Hirota, S. Hosobe, Y. Takano, K. Saito, E. Furuta, M. Iiizumi, S. Mohinta, M. Watabe, C. Chalfant, K. Watabe, Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells, Cancer Res. 66 (2006) 5934-5940. (Pubitemid 43927149)
25. J.N. Li, M. Gorospe, F.J. Chrest, T.S. Kumaravel, M.K. Evans, W.F. Han, E.S. Pizer, Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53, Cancer Res. 61 (2001) 1493-1499. (Pubitemid 34292578)
26. J.L. Little, S.J. Kridel, Fatty acid synthase activity in tumor cells, in: J.P. Quinn, X. Wang (Eds.), Lipids in Health and Disease, Springer Science + Business Media B.V., USA, 2008, pp. 169-185.
27. J.V. Swinnen, P.P. Van Veldhoven, L. Timmermans, E. De Schrijver, K. Brusselmans, F. Vanderhoydonc, et al., Fatty acid synthase drives the synthesis of phospholipids partitioning into detergent-resistant membrane microdomains, Biochem. Biophys. Res. Commun. 302 (2003) 898-903. (Pubitemid 36294061)
28. F.P. Kuhajda, Fatty acid synthase and cancer: new application of an old pathway, Cancer Res. 66 (2006) 5977-5980.
29. M.I. Pörn, J.P. Slotte, Reversible effects of sphingomyelin degradation on cholesterol distribution and metabolism in fibroblasts and transformed neuroblastoma cells, Biochem. J. 271 (1990) 121-126. (Pubitemid 20331206)
30. S. Rossi, E. Graner, P. Febbo, L. Weinstein, N. Bhattacharya, T. Onody, G. Bubley, S. Balk, M. Loda, Fatty acid synthase expression defines distinct molecular signatures in prostate cancer, Mol. Cancer Res. 1 (2003) 707-715. (Pubitemid 37025589)
31. A.A. Spector, R.E. Kiser, G.M. Denning, S.W. Koh, L.E. DeBault, Modification of the fatty acid composition of cultured human fibroblasts, J. Lipid Res. 20 (1979) 536-547. (Pubitemid 9215381)
32. J.P. Slotte, E.L. Bierman, Depletion of plasma-membrane sphingomyelin rapidly alters the distribution of cholesterol between plasma membranes and intracellular cholesterol pools in cultured fibroblasts, Biochem. J. 250 (1988) 653-658. (Pubitemid 18077472)
33. Y. Lange, M.H. Swaisgood, B.V. Ramos, T.L. Steck, Plasma membranes contain half the phospholipid and 90% of the cholesterol and sphingomyelin in cultured human fibroblasts, J. Biol. Chem. 264 (1989) 3786-3793. (Pubitemid 19072257)
34. M.A. Yorek, P.H. Figard, T.L. Kaduce, A.A. Spector, A comparison of lipid metabolism in two human retinoblastoma cell lines, Invest. Ophthalmol. Vis. Sci. 26 (1985) 1148-1154. (Pubitemid 15003358)
35. K. Brusselmans, R. Vrolix, G. Verhoeven, J.V. Swinnen, Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity, J. Biol. Chem. 280 (2005) 5636-5645. (Pubitemid 40280043)
36. J. Ross, A.M. Najjar, M. Sankaranarayanapillai, W.P. Tong, K. Kaluarachchi, S.M. Ronen, Fatty acid synthase inhibition results in a magnetic resonance-detectable drop in phosphocholine, Mol. Cancer Ther. 7 (2008) 2556-2565.
37. E.S. Pizer, C. Jackisch, F.D. Wood, G.R. Pasternack, N.E. Davidson, F.P. Kuhajda, Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells, Cancer Res. 56 (1996) 2745-2747. (Pubitemid 26175731)
38. E. Rysman, K. Brusselmans, K. Scheys, L. Timmermans, R. Derua, S. Munck, et al., De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation, Cancer Res. 70 (2010) 8117-8126.
39. K.G. Zecchin, F.A. Rossato, H.F. Raposo, D.R. Melo, L.C. Alberici, H.C. Oliveira, Inhibition of fatty acid synthase in melanoma cells activates the intrinsic pathway of apoptosis, Lab. Invest. 91 (2011) 232-240.
40. P.R. Deepa, V. Nalini, K. Mallikarjuna, S. Vandhana, S. Krishnakumar, Oxidative stress in retinoblastoma: correlations with clinicopathologic features and tumor invasiveness, Curr. Eye Res. 34 (2009) 1011-1018.
41. S. Vandhana, T.S. Ramyaa Lakshmi, D. Indra, P.R. Deepa, S. Krishnakumar, Microarray analysis and biochemical correlations of oxidative stress responsive genes in retinoblastoma, Curr. Eye Res. 37 (2012) 830-841.
42. V. Chajès, M. Cambot, K. Moreau, G.M. Lenoir, V. Joulin, Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival, Cancer Res. 66 (2006) 5287-5294. (Pubitemid 43844953)
43. V.R. Tandon, S. Sharma, A. Mahajan, G.H. Bardi, Oxidative stress: a novel strategy in cancer treatment, New Horiz. 7 (2005) 1-3.